Načítá se...
CAR T-cell therapy for pleural mesothelioma: rationale, preclinical development, and clinical trials
The aim of adoptive T-cell therapy is to promote tumor-infiltrating immune cells following the transfer of either tumor-harvested or genetically engineered T lymphocytes. A new chapter in adoptive T-cell therapy began with the success of chimeric antigen receptor (CAR) T-cell therapy. T cells harves...
Uloženo v:
| Vydáno v: | Lung Cancer |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8184643/ https://ncbi.nlm.nih.gov/pubmed/33972125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2021.05.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|